NCT05241873 2025-02-10(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsBlueprint Medicines CorporationPhase 1 Terminated103 enrolled
NCT01607905 2023-01-26Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor CancerKaryopharm Therapeutics IncPhase 1 Completed192 enrolled 29 charts